Skip to main content

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Imagerie cérébrale Corti Corvol Parkinson

How is Parkinson’s disease diagnosed?

Last update: 25/07/2025 Reading time: 1min

Diagnosing Parkinson’s disease is based on identifying Parkinsonian syndrome combined with at least two ‘supporting’ criteria.

Diagnosing Parkinson’s Disease

Diagnosing Parkinson’s Disease

Parkinson’s Disease is diagnosed after ruling out the possibility of other conditions that may present with the same early symptoms, such as Wilson’s disease in young patients, or vascular lesions or hydrocephalus in rarer cases.

Parkinson’s Disease is a combination of parkinsonian syndrome and at least 2 other criteria of a possible 4:

  • An improvement in parkinsonian syndrome disorders through dopaminergic treatment
  • The onset of involuntary, erratic movements (dyskinesias) after many years of dopamine treatment.
  • A unilateral or asymmetric resting tremor.
  • A decrease (hyposmia) or even complete disappearance (anosmia) of a patient’s sense of smell.

Patients may also present with ‘non-motor’ symptoms such as intestinal disorders, apathy and REM sleep disorders.

At Paris Brain Institute

At Paris Brain Institute

Several recent projects, inter alia projects led by the team of Marie Vidailhet and Stéphane Lehericy at Paris Brain Institute, have found that the ‘non-motor’ symptoms of Parkinson’s disease come early and occur before the motor symptoms. These clinical signs could therefore be very effective diagnostic markers and even serve as prognostic markers of disease progression. In the ICEBERG study, the team focused on REM sleep disorders and eye movements.

This study also identified a marker for the progression of dopamine neuron loss visible on MRI scans: neuromelanin. This protein plays a protective role in neurons by capturing toxic molecules such as iron.

Diagnostic de Parkinson en IRM

MRI performed by the CENIR imaging platform at Paris Brain Institute. The amount of neuromelanin observed by MRI in the dark matter. (Left: a healthy individual; Center: a patient in the early stages of Parkinson’s disease; Right: a patient whose Parkinson’s disease has progressed for some time.)

There is a decrease in neuromelanin in patients that increases over time, because of the degeneration of dopaminergic neurons that is characteristic of Parkinson’s disease.

Our news on the subject

Un iceberg
The ICEBERG cohort, 10 years of collective scientific and medical mobilization
The ICEBERG cohort, initiated 10 years ago, is interested in studying factors predictive of the onset and progression of Parkinson’s disease.
05.15.2025 Research, science & health
Un chercheur
World Parkinson's Day 2022: where does research stand?
On the occasion of World Parkinson's Day, which will be held on 11 April 2022, the Paris Brain Institute takes stock of the latest advances in research and the challenges that remain in the fight against the second most common neurodegenerative...
04.11.2022 Research, science & health
image
Artificial Intelligence-based MRI biomarker of Isolated REM Sleep Behavior Disorder and Parkinson's disease
Rahul Gaurav, a research Engineer in the MOV’IT team led by Pr. Stéphane Lehéricy and Pr. Marie Vidailhet, at the Paris Brain Institute, developed an artificial intelligence framework to investigate fully automatic neurodegeneration in the substantia...
02.18.2022 Research, science & health
Réprésentation du danse lors du petit déjeuner
2023 Art-Science Breakfast: restoring movement for Parkinson’s patients
In partnership with the Paris+ par Art Basel contemporary art fair, the 12th edition of the Art-Science Breakfast took place on October 18, 2023 at Café de l’Homme. Thanks to support from the NRJ Foundation at Institut de France and the incredible...
10.20.2023 Support
image
How to discern impulsivity from alteration of anticipation?
In everyday life, we all need to anticipate our actions. On the road, for example, we need to start or cross when the light turns green. While the light is red, our brain prepares to act as quickly as possible as soon as the color changes because we...
10.13.2022 Research, science & health
image
Genetics of early-onset parkinsonism with intellectual disability
A research team from the Paris Brain Institute (Inserm/CNRS/Sorbonne University/AP-HP) just identified mutations in familial cases with early-onset Parkinsonism and intellectual disability. Genetic studies on two affected siblings pairs highlighted...
09.29.2022 Research, science & health
See all our news